Limits on Autonomous Clinical Decision-Making by AI: The Need for Independent Validation
Legislatures around the world are increasingly drawing human-judgment lines to limit autonomous clinical decision-making by AI in healthcare. This development not only affects hospitals and clinics but also insurers, pharmaceutical companies, and other stakeholders across healthcare’s value chain.
What is happening?
The rise of AI-powered diagnosis and treatment has raised concerns about accountability and liability for decisions made without human oversight. In response, governments have introduced regulations to ensure that these systems are transparent, explainable, and subject to human review. The key challenge lies in striking a balance between the benefits of autonomy and the need for human judgment.
Why it demands action now?
Organisations buying or deploying AI in healthcare must consider three critical risks: capability risk (can the technology accurately diagnose and treat patients?), governance risk (is the decision defensible when regulators ask questions?), and liability risk (what is the organisation accountable for when the AI makes an error?). These risks are heightened by the fact that vendors often exaggerate their products’ capabilities, while internal teams may be too close to the decision-making process to identify potential flaws.
The action?
To mitigate these risks, prudent organisations should take the following steps: first, assess the vendor’s claims and test the AI against real-world scenarios within 6-12 months; second, establish clear governance procedures for AI-powered decisions, including human oversight and explanation mechanisms, by Q2 of the next year; third, implement a plan to address liability exposure through insurance coverage or internal risk management strategies within 18-24 months.
How Straven helps?
Straven & Co examines AI decisions before they are acted on. Our independent validation process assesses the proposed solution against our clients’ real operations, people, governance obligations, and legal and regulatory exposure. This delivers a plain verdict: proceed, proceed with conditions, or do not. Our independence is key to this assessment – we have no product to sell and earn nothing by recommending more.
Straven & Co examines AI decisions before they are acted on: stravenandco.com